首页> Frontiers in endocrinology> Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III.

Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jianhao,Huang

第一单位： Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.;Shantou University Medical College, Shantou, China.

作者： Jianhao,Huang ^[1] ; Hongyan,Shi ^[2] ; Muye,Song ^[3] ; Jinan,Liang ^[2] ; Zhiyuan,Zhang ^[2] ; Xiaohang,Chen ^[1] ; Yongchen,Liu ^[4] ; Sanming,Wang ^[4] ; Zeyu,Wu ^[4]

作者单位： Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.;Shantou University Medical College, Shantou, China. ^[1] Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.;The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. ^[2] Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.;School of Medicine, South China University of Technology, Guangzhou, China. ^[3] Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. ^[4]

关键词 autoimmune thyroid antibodies fine needle aspirate (FNA)microcalcification thyroid cancer tumor size

DOI 10.3389/fendo.2024.1517690

PMID 39619327

发布时间 2024-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交